Almirall, S.A. (E2Z)
FSX
Closed
Oct 7, 2026
Day's Range
10.0852 wk Range
10.04Overview - E2Z - Almirall, S.A.
Key Statistics
Valuation
Enterprise Value
2.29B
P/E (Trailing)
‪36.42‬
Price / Sales (TTM)
‪1.91‬
Price / Book
‪1.45‬
EV / EBITDA
‪10.41‬
Profitability
Gross Margin
‪185.11%‬
Profit Margin
‪5.11%‬
Operating Margin
‪13.33%‬
Return on Assets
‪2.69%‬
Return on Equity
‪3.95%‬
Ownership
Shares Outstanding
217.60M
Float
78.27M
Held by Insiders
‪64.07%‬
Held by Institutions
‪16.60%‬
Price stats
Beta
‪0.16‬
50-Day Avg
‪10.60‬
200-Day Avg
‪11.73‬
Dividends
Payout Ratio
‪67.59%‬
Frequency
Annual
Market Cap - E2Z - Almirall, S.A.
Peers - E2Z - Almirall, S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
Profile Summary - E2Z - Almirall, S.A.
About
Almirall, S.A. is a Spanish pharmaceutical company specializing in medical dermatology, headquartered in Barcelona and founded in 1944. It focuses on researching, developing, manufacturing, and marketing innovative medicines to address unmet needs in skin health, particularly for conditions like psoriasis, atopic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
